Policy paper

Impact of AI on the regulation of medical products

Implementing the Artificial Intelligence (AI) White Paper principles.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 30 April 2024

Documents

Impact of AI on the regulation of medical products

PDF, 616 KB, 17 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Impact of AI on the regulation of medical products

HTML

Details

This publication provides on update on the MHRA’s use of AI as a regulator of AI products, as a public service organisation delivering time-critical decisions and as an organisation making evidence-based decisions that impact public safety. It is the MHRA response to the Secretary of State letter of 1 February 2024.

Published 30 April 2024